Skip to content

SPYRE THERAPEUTICS, INC.: filings

Every SPYRE THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-04fiscal Q2 202626770001636282-26-000096
10-Q2026-05-05fiscal Q1 202626550001636282-26-000050
10-K2026-02-19fiscal FY 202530810001636282-26-000020
10-Q2025-11-04fiscal Q3 202526820001636282-25-000102
10-Q2025-08-05fiscal Q2 202526790001636282-25-000089
10-Q2025-05-08fiscal Q1 202525550001636282-25-000049
10-K2025-02-27fiscal FY 202431830001636282-25-000020
10-Q/A2024-11-18fiscal Q3 2024341110001636282-24-000113
10-Q/A2024-11-18fiscal Q2 2024331050001636282-24-000111
10-Q/A2024-11-18fiscal Q1 202433680001636282-24-000109
10-K/A2024-11-18fiscal FY 2023401030001636282-24-000107
10-Q2024-11-07fiscal Q3 2024341110001636282-24-000083
10-Q2024-08-07fiscal Q2 2024331050001636282-24-000051
10-Q2024-05-09fiscal Q1 202433700001636282-24-000037
10-K2024-02-29fiscal FY 2023401070001636282-24-000005
10-Q2023-11-09fiscal Q3 2023381150001636282-23-000018
10-Q2023-08-11fiscal Q2 2023391100000950170-23-041590
10-Q2023-05-11fiscal Q1 202340800000950170-23-020825
10-K2023-03-02fiscal FY 2022451170000950170-23-005705
10-Q2022-11-03fiscal Q3 2022411220000950170-22-021529
10-Q2022-08-04fiscal Q2 2022411180001564590-22-027895
10-Q2022-05-05fiscal Q1 202234710001564590-22-018006
10-K2022-03-08fiscal FY 2021411020001564590-22-008995
10-Q2021-11-04fiscal Q3 202135970001564590-21-054228
10-Q2021-08-05fiscal Q2 202135930001564590-21-041216
10-Q2021-05-10fiscal Q1 202132650001564590-21-025791
10-K2021-03-18fiscal FY 2020391120001564590-21-014021
10-Q2020-11-05fiscal Q3 202032890001564590-20-050906
10-Q2020-08-10fiscal Q2 202032850001564590-20-038651
10-Q2020-05-07fiscal Q1 202031640001564590-20-022403
10-K2020-02-24fiscal FY 2019391120001564590-20-005888
10-Q2019-11-06fiscal Q3 201936940001564590-19-040692
10-Q2019-08-06fiscal Q2 201936900001564590-19-028999
10-Q2019-05-07fiscal Q1 201937710001564590-19-016211
10-K2019-03-07fiscal FY 2018361170001564590-19-006771
10-Q2018-11-08fiscal Q3 201833840001564590-18-028293
10-Q2018-08-09fiscal Q2 201829780001564590-18-020760
10-Q2018-05-08fiscal Q1 201828580001564590-18-011484
10-K2018-03-13fiscal FY 201732990001564590-18-005404
10-Q2017-11-07fiscal Q3 201728740001564590-17-022228
10-Q2017-08-09fiscal Q2 201728740001564590-17-016937
10-Q2017-05-09fiscal Q1 201728580001564590-17-009615
10-K2017-03-23fiscal FY 201632970001564590-17-005137
10-Q2016-11-09fiscal Q3 201629780001564590-16-028480
10-Q2016-08-09fiscal Q2 201629760001564590-16-023459
10-Q2016-05-19fiscal Q1 201629580001564590-16-019683

Inspect the source

Entity
SPYRE THERAPEUTICS, INC. / CIK 0001636282
Captured
2026-09-21T17:22:15.187Z
SEC response SHA-256
b9f7b078b54e59d609174c52c2bde58cf8bd64b6ee1ec8af2baa8fc0a97dfce1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001636282.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))